Published in Lab Business Week, March 12th, 2006
As mentioned in the earlier announcement, the company is in continuing discussions with the Securities and Exchange Commission with respect to the accounting treatment for certain contracts entered into after January 2004. The company at that time noted that the filing of its Quarterly Report on Form 10-Q for the quarter ending December 31, 2005 could be delayed as a result of the restatement process.
Due to the continuing discussions with the SEC, the company has now determined that it will be unable to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.